Literature DB >> 1831684

5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.

V C Middlefell1, T L Price.   

Abstract

The racemic 5-HT3 receptor antagonist, zacopride (10-100 micrograms kg-1, i.m.) evoked an emetic response in ferrets. This property appeared to reside totally in the S-enantiomer which also produced emesis over the same dose range. This emesis could be prevented by pretreatment with ondansetron (1 mg kg-1, i.m.) or by R-zacopride (100 micrograms kg-1, i.m.). In urethane-anaesthetized ferrets, S-zacopride (0.3 micrograms kg-1, i.v.) evoked a profound Bezold-Jarisch reflex which was blocked by both ondansetron (30 micrograms kg-1, i.v.) and by R-zacopride (100 micrograms kg-1, i.v.). These results suggest that, in the ferret, S-zacopride possesses 5-HT3 receptor agonist properties which may be responsible for the emetic effect. In contrast R-zacopride does not appear to possess 5-HT3 receptor agonist properties in this species.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831684      PMCID: PMC1908073          DOI: 10.1111/j.1476-5381.1991.tb12292.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

1.  Zacopride, a potent 5-HT3 antagonist.

Authors:  W W Smith; L F Sancilio; J B Owera-Atepo; R J Naylor; L Lambert
Journal:  J Pharm Pharmacol       Date:  1988-04       Impact factor: 3.765

Review 2.  The 5-HT4 receptor: naughty, but nice.

Authors:  D E Clarke; D A Craig; J R Fozard
Journal:  Trends Pharmacol Sci       Date:  1989-10       Impact factor: 14.819

3.  Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.

Authors:  G L King
Journal:  J Pharmacol Exp Ther       Date:  1990-06       Impact factor: 4.030

4.  The antiemetic profile of zacopride.

Authors:  W L Smith; R S Alphin; C B Jackson; L F Sancilio
Journal:  J Pharm Pharmacol       Date:  1989-02       Impact factor: 3.765

5.  Prevention and treatment of the gastric symptoms of radiation sickness.

Authors:  A Dubois; N Fiala; C A Boward; V Bogo
Journal:  Radiat Res       Date:  1988-09       Impact factor: 2.841

6.  Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.

Authors:  B Costall; A M Domeney; R J Naylor; F D Tattersall
Journal:  Neuropharmacology       Date:  1987-09       Impact factor: 5.250

7.  The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride.

Authors:  W L Smith; E M Callaham; R S Alphin
Journal:  J Pharm Pharmacol       Date:  1988-02       Impact factor: 3.765

  7 in total
  2 in total

Review 1.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

2.  The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.

Authors:  D J Bill; J Coleman; I Hallett; V C Middlefell; K F Rhodes; A Fletcher
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.